tifluadom has been researched along with ketazocine in 6 studies
| Studies (tifluadom) | Trials (tifluadom) | Recent Studies (post-2010) (tifluadom) | Studies (ketazocine) | Trials (ketazocine) | Recent Studies (post-2010) (ketazocine) |
|---|---|---|---|---|---|
| 78 | 0 | 0 | 108 | 3 | 1 |
| Protein | Taxonomy | tifluadom (IC50) | ketazocine (IC50) |
|---|---|---|---|
| Mu-type opioid receptor | Homo sapiens (human) | 0.13 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cooper, SJ; Jackson, A; Kirkham, TC | 1 |
| Hayes, A; Kelly, A | 1 |
| Beck, T; Krieglstein, J | 1 |
| Leander, JD | 1 |
| Grace, M; Kneip, J; Levine, AS; Morley, JE; Zeugner, H | 1 |
| Gosnell, BA; Grace, M; Kneip, J; Levine, AS; Morley, JE | 1 |
1 review(s) available for tifluadom and ketazocine
| Article | Year |
|---|---|
Endorphins and food intake: kappa opioid receptor agonists and hyperphagia.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Analgesics; Animals; Benzodiazepines; Benzomorphans; Butorphanol; Choice Behavior; Cyclazocine; Diuresis; Drinking; Dynorphins; Eating; Endorphins; Ethylketocyclazocine; Humans; Morphine; Narcotic Antagonists; Phenazocine; Pyrrolidines; Receptors, Opioid; Receptors, Opioid, kappa; Satiety Response | 1985 |
5 other study(ies) available for tifluadom and ketazocine
| Article | Year |
|---|---|
Profile of activity of kappa receptor agonists in the rabbit vas deferens.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Analgesics; Animals; Benzodiazepines; Benzomorphans; Butorphanol; Cyclazocine; Ethylketocyclazocine; In Vitro Techniques; Male; Muscle Contraction; Muscle, Smooth; Nalorphine; Naloxone; Pyrrolidines; Rabbits; Receptors, Opioid; Receptors, Opioid, kappa; Receptors, Opioid, mu; Vas Deferens | 1985 |
The effects of tifluadom and ketazocine on behaviour, dopamine turnover in the basal ganglia and local cerebral glucose utilization of rats.
Topics: Animals; Benzodiazepines; Brain; Corpus Striatum; Cyclazocine; Dopamine; Ethylketocyclazocine; Glucose; Male; Motor Activity; Nucleus Accumbens; Rats; Rats, Inbred Strains | 1986 |
Kappa opioid agonists and antagonists: effects on drinking and urinary output.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Animals; Benzodiazepines; Benzomorphans; Butorphanol; Clonidine; Cyclazocine; Drinking; Ethylketocyclazocine; Naloxone; Pyrrolidines; Rats; Rats, Inbred Strains; Receptors, Opioid; Receptors, Opioid, kappa; Urination; Vasopressins | 1984 |
The effect of the opioid-benzodiazepine, tifluadom, on ingestive behaviors.
Topics: Animals; Benzodiazepines; Butorphanol; Cyclazocine; Drinking Behavior; Ethylketocyclazocine; Feeding Behavior; Male; Morphine; Naloxone; Rats; Rats, Inbred Strains; Receptors, Opioid; Receptors, Opioid, kappa | 1983 |
The kappa opioid receptor, ingestive behaviors and the obese mouse (ob/ob).
Topics: Animals; Appetite; Benzodiazepines; Body Weight; Butorphanol; Cyclazocine; Dose-Response Relationship, Drug; Drinking; Eating; Ethylketocyclazocine; Male; Mice; Mice, Obese; Receptors, Opioid; Receptors, Opioid, kappa | 1983 |